Pfizer: Global Awards for Advancing Chronic Pain Research

Grants of up to $150,000 will be awarded in support of innovative, novel research proposals that aim to advance the understanding and management of chronic pain due to osteoarthritis (OA).

Pfizer Inc. has announced a call for proposals for its fourth Global Awards for Advancing Chronic Pain Research (ADVANCE) competitive grants program.

The program is looking for studies that aim to advance: the evaluation of unmet medical needs in pain management associated with OA — including benefit-risk assessment and patient preference in the choice of pain medication for patients with comorbid conditions (e.g., cardiovascular disease or history of substance abuse); understanding how risks associated with long-term use of analgesics are assessed currently; treatment of chronic pain in special populations (e.g., postsurgical, elderly); evaluation of multi-disciplinary approaches to OA management (e.g., physical therapy, cognitive behavioral therapy [CBT]) and their combination with pharmacological treatment; understanding and predicting response to treatment, disease state, and course of OA (normal and rapid trajectories); approaches to improving adherence to therapy or therapeutic regimes for pain associated with OA; the use of patient characteristics such as biomarkers or other objective evaluations (e.g., quantitative sensory testing [QST], imaging modalities) in the assessment and management of OA to better understand disease course; and evaluation of improved function — such as how changes of physical function are assessed in clinical practice in patients with OA, and how current physical function assessment could be improved; how individual goal setting can contribute to treatment outcome (including pain and function); and what impact the improved physical function has on the patients’ quality of life.

The Principal Investigator must hold a doctoral degree (MD, PhD, PharmD, or equivalent). Investigators must be affiliated with an academic or medical institution.

Please contact Daniel Hadley if you are interested in applying to this opportunity.